acetylcysteine has been researched along with Bladder Diseases in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhatnagar, A; Conklin, DJ; Haberzettl, P; Lesgards, JF; Prough, RA; Srivastava, S | 1 |
Harada, T; Horiuchi, H; Ishitsuka, K; Kashimoto, Y; Kuwahara, M; Nakashima, N; Ohnuma, A; Takahashi, N; Yoshida, T | 1 |
Ahmed, T; Fraiser, LH; Kehrer, JP; Mamiya, B; Ramu, K | 1 |
Benjamin, RS; Legha, SS; Nicaise, C; Patel, SR | 1 |
Harris, E; Levy, J; Levy, L | 1 |
Jacobs, D; Marion, D; Reckler, J; Rodman, JS; Rotterdam, H; Vaughan, ED | 1 |
Berra, S; Galli, L | 1 |
1 review(s) available for acetylcysteine and Bladder Diseases
Article | Year |
---|---|
Single-agent ifosfamide studies in sarcomas of soft tissue and bone: the M.D. Anderson experience.
Topics: Acetylcysteine; Bone Neoplasms; Fluid Therapy; Humans; Ifosfamide; Mesna; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Urinary Bladder Diseases | 1993 |
6 other study(ies) available for acetylcysteine and Bladder Diseases
Article | Year |
---|---|
Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity.
Topics: Acetylcysteine; Acrolein; Animals; Antineoplastic Agents, Alkylating; Blotting, Western; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Cystitis; Glutathione Transferase; Hemorrhage; Immunohistochemistry; In Situ Nick-End Labeling; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Organ Size; Reverse Transcriptase Polymerase Chain Reaction; Urinary Bladder; Urinary Bladder Diseases | 2009 |
The enhancing effect of the antioxidant N-acetylcysteine on urinary bladder injury induced by dimethylarsinic acid.
Topics: Acetylcysteine; Animals; Antioxidants; Biomarkers; Cacodylic Acid; Cell Proliferation; Female; Immunohistochemistry; MAP Kinase Signaling System; Oxidative Stress; Rats; Rats, Inbred F344; Urinary Bladder Diseases; Urothelium | 2011 |
Acrolein mercapturates: synthesis, characterization, and assessment of their role in the bladder toxicity of cyclophosphamide.
Topics: Acetylcysteine; Acrolein; Animals; Chromatography, Thin Layer; Cyclophosphamide; Hemoglobins; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Mice, Inbred ICR; Phenylhydrazines; Semicarbazones; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Urinary Bladder Diseases | 1995 |
Inhibition of cylophosphamide (CPA)-induced bladder toxicity by N-acetylcysteine (NAC) in rats.
Topics: Acetylcysteine; Animals; Cyclophosphamide; Edema; Immunosuppression Therapy; Leukocyte Count; Rats; Time Factors; Urinary Bladder Diseases | 1975 |
Urothelial injury to the rabbit bladder from various alkaline and acidic solutions used to dissolve kidney stones.
Topics: Acetylcysteine; Acids; Animals; Citrates; Citric Acid; Creatinine; Dogs; Epithelium; Kidney Calculi; Rabbits; Sodium Chloride; Urinary Bladder Diseases | 1986 |
[Topical use of N-acetyl-L-cysteine in some urological diseases].
Topics: Acetylcysteine; Aged; Humans; Male; Middle Aged; Postoperative Complications; Prostatic Hyperplasia; Prostatic Neoplasms; Urinary Bladder Diseases; Urinary Catheterization; Urinary Tract Infections; Urologic Diseases | 1968 |